Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
about
Vaccinology in the third millennium: scientific and social challengesA critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansImpact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritisSeasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.AID in aging and autoimmune diseases.Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individualsYouth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus.Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.Influenza vaccine responses in older adults.Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States.Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titersRandomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine TrialsLong-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.Pneumonia immunization in older adults: review of vaccine effectiveness and strategiesQuantifying the economic value and quality of life impact of earlier influenza vaccination.Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients - an 18-week, open-label trialDouble dose vs. standard dose influenza vaccination in patients with heart failure: a pilot studyPersistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season.Vaccination in the elderly: an immunological perspective.Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine.Immunosenescence: what does it mean to health outcomes in older adults?Immunosenescence and vaccination in nursing home residents.Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.Lack of persistence of influenza vaccine antibody titers in patients with heart failure.Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine.Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
P2860
Q24261399-DBD0C9A1-38C2-4EF2-9AE8-4FC2BBE1D782Q28072372-0593534C-A787-4291-8411-8EBE516FD6D6Q30357450-2F672070-7E82-496C-B59E-F5224012DDEBQ30389669-8AF0B497-964A-4560-AF48-75CE6C8D5CCBQ30394995-FA4B6FB2-12EF-4962-A5B3-1F98BDEB90B6Q30400385-2BA0D0E0-D130-4422-A45F-BBAD19C8FD9FQ30412266-CA2DC0C4-515C-4780-97EA-F8B52FE1B12BQ30421821-93B2CAA6-9A2D-467C-A636-0857BF68A879Q30424165-763A996A-ACE9-4A2E-B6EE-FCB48FCC3A07Q33922317-1C295EC1-833D-4E72-B8CD-74E9E8A90806Q34030735-60E8522E-D6EF-42BF-9740-69205A947DCDQ34097791-ED3770D7-EFEF-4BDB-9697-16264199A61EQ34433508-9B7FE0D6-428A-4102-801E-421670469415Q34511678-A3476863-4C99-4D2E-84AC-E061CDB4DE8DQ34705027-7025A161-D94D-47D0-9619-3A166C5F9A2EQ34993133-AFBC9D7E-F26F-4D01-AD75-E4437A695AC4Q35043898-58EEEC7F-CE25-4EEA-A159-561A38D6F163Q35589650-873DADB5-40FF-42B3-A7CE-7DB800C9B524Q35797338-D89F65DA-F09C-49CC-B9A4-BCFD19DEEBF0Q35887557-44365B30-FA0E-4775-BB60-8E9BD21EBA9AQ35965224-F12F8A44-4194-42F6-A654-76A0023A71CAQ36253150-CCD2511B-CAEF-48E0-A7AE-E52618E5B3D7Q36306922-80024C0B-FBC1-4225-AB27-023A29E3D1D8Q36317045-2569D24D-A547-4CA5-A755-EF721BCE1298Q36376043-7368AA12-0D68-43AA-9396-0B9E9EC09527Q36393396-AD0F1668-A00F-4CC2-92CD-0D9D3CE9A676Q36403075-A4E2778D-A361-491F-A11D-CEF0EF7988D6Q36574698-6E255AC3-1098-4367-9C41-1F131289F0ACQ36782427-FCA0123F-0857-4B62-89AE-3AF6297F8867Q36849805-7BC0FA2B-183B-4357-885D-6E91C86ECC3CQ37084886-48556105-E060-4045-B2CE-21C7F5090819Q37107424-5A126BCB-E096-4F18-A5F5-FA15BB0D9D7EQ37141069-6EE83EB1-4C73-489C-9D97-5906720FD777Q37301037-9F01FF1C-C8C4-4873-8AC1-1F3BAA22CB92Q37367442-5638640D-0BD6-4D9D-A369-18B1100F4B59Q37461377-EDA6C2A7-CBF6-4633-84F1-191223864BF8Q37620276-4E3AAE48-144B-43A9-B751-65EC577DCCB6Q37694883-20D22778-72E0-4B97-B280-EE0E0F6A0707Q37798007-DC5B9209-9186-44AD-AE18-609708BA82C5Q39675557-CB682282-D508-4DE2-9075-DD405A772CC8
P2860
Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rapid decline of influenza vac ...... is it real, or is it relevant?
@en
Rapid decline of influenza vac ...... is it real, or is it relevant?
@nl
type
label
Rapid decline of influenza vac ...... is it real, or is it relevant?
@en
Rapid decline of influenza vac ...... is it real, or is it relevant?
@nl
prefLabel
Rapid decline of influenza vac ...... is it real, or is it relevant?
@en
Rapid decline of influenza vac ...... is it real, or is it relevant?
@nl
P2860
P356
P1476
Rapid decline of influenza vac ...... is it real, or is it relevant?
@en
P2093
Danuta M Skowronski
S Aleina Tweed
P2860
P304
P356
10.1086/524146
P407
P577
2008-02-01T00:00:00Z